HC Wainwright Lowers Earnings Estimates for Alpha Cognition

Alpha Cognition Inc. (NASDAQ:ACOG) – Stock analysts at HC Wainwright cut their FY2025 earnings per share estimates for shares of Alpha Cognition in a research report issued to clients and investors on Monday, November 24th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($1.14) per share for the year, down from their previous estimate of ($1.12). HC Wainwright has a “Buy” rating and a $18.00 price objective on the stock. HC Wainwright also issued estimates for Alpha Cognition’s Q4 2025 earnings at ($0.32) EPS, Q1 2026 earnings at ($0.19) EPS, Q2 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.17) EPS and FY2026 earnings at ($0.83) EPS.

Separately, Wall Street Zen raised shares of Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday, November 15th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $18.00.

Alpha Cognition Price Performance

Shares of Alpha Cognition stock opened at $6.09 on Wednesday. The firm has a 50 day simple moving average of $6.79 and a 200 day simple moving average of $8.38. The firm has a market cap of $132.41 million, a P/E ratio of -4.45 and a beta of 2.62. Alpha Cognition has a fifty-two week low of $3.75 and a fifty-two week high of $11.54.

Alpha Cognition (NASDAQ:ACOG) last released its quarterly earnings results on Thursday, November 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.13. The business had revenue of $2.84 million during the quarter, compared to the consensus estimate of $3.21 million.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ACOG. Geode Capital Management LLC bought a new stake in shares of Alpha Cognition in the second quarter valued at about $112,000. Massar Capital Management LP bought a new position in shares of Alpha Cognition in the second quarter worth $116,000. Berkshire Asset Management LLC PA raised its stake in Alpha Cognition by 50.7% in the third quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock valued at $116,000 after purchasing an additional 6,000 shares in the last quarter. Zullo Investment Group Inc. bought a new stake in Alpha Cognition during the third quarter worth about $127,000. Finally, Two Sigma Investments LP acquired a new stake in shares of Alpha Cognition during the 3rd quarter worth approximately $148,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.